abstract |
The present invention relates to substituted imidazo [1,2-A] pyridin-2-ylamine compounds, for example compounds of formula (A), and pharmaceutical compositions; And a method of using the same for treating or ameliorating at least one symptom of Janus kinase-mediated disease. (A) |